MLchartDataset catalogue

bispecific antibody JNJ-70218902

Term · Oncology and biomedicine · MLC-T-ONC-012038

A T-cell redirecting agent and bispecific antibody targeting an as of yet undisclosed tumor-associated antigen (TAA) expressed on tumor cells and the CD3 receptor complex expressed on T cells, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody JNJ-70218902 binds to both CD3 on T cells and a TAA expressed on tumor cells. The resulting cross-linkage activates and redirects T cells to the TAA-expressing tumor cells. This results in T-cell-mediated lysis of tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-012038
FieldOncology and biomedicine
SynonymsT-cell-redirecting agent JNJ-70218902
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012038",
  "term": "bispecific antibody JNJ-70218902",
  "field": "Oncology and biomedicine",
  "definition": "A T-cell redirecting agent and bispecific antibody targeting an as of yet undisclosed tumor-associated antigen (TAA) expressed on tumor cells and the CD3 receptor complex expressed on T cells, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody JNJ-70218902 binds to both CD3 on T cells and a TAA expressed on tumor cells. The resulting cross-linkage activates and redirects T cells to the TAA-expressing tumor cells. This results in T-cell-mediated lysis of tumor cells.",
  "synonyms": [
    "T-cell-redirecting agent JNJ-70218902"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bispecific-antibody-jnj-70218902/"
}

Record 3,615 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.